What's on Your Mind?

In Texas, a Republican senator just introduced a bill that would require wastewater treatment facilities to do some extra testing—essentially making guidelines more stringent than those currently federally mandated. While that might sound like an uncharacteristically environmentally forward cause for a Texas Republican, what the senator wants to test for may give you even greater pause: It’s the abortion medication mifepristone. On Monday, Senator Bryan Hughes of Texas’s first district introduced bill SB1976, which would require testing for a number of “urinary metabolites in the form of gluconates,” including hormones like testosterone; ethinyl estradiol (which…

Early this morning, the House voted 215–214 to pass a sweeping budget reconciliation bill with provisions that include a cancellation or phaseout for just about everything that was in the Inflation Reduction Act. The measure, which now heads to the Senate, is being described by clean energy and environmental groups as a monumental betrayal of the country that will cost jobs and increase electricity bills. But during the floor debate overnight, the energy parts of the bill were an afterthought to higher priority issues for members of both parties, such as tax cuts, revisions to Medicaid, and a desire to support or oppose the agenda of President Donald The President…

I was interviewing for a job as a customer service agent with Anna. She had a low, pleasant voice and she’d nailed the pronunciation of my name—something few people do. I wanted to make a good impression except I had no idea what Anna was thinking because Anna couldn’t think. Anna wasn’t technically a person. She was AI. Not only is AI changing how we do our jobs, it’s also changing how we get jobs. This ranges from using AI to screen resumes, schedule interviews, even conduct them. According to a 2025 report, 20% of companies are using AI to interview candidates. Even so, nothing can replace human recruiters, the folks who’ve deployed Anna into the wild stressed …

It has been an odd few weeks for generative AI systems, with ChatGPT suddenly turning sycophantic, and Grok, xAI’s chatbot, becoming obsessed with South Africa. Fast Company spoke to Steven Adler, a former research scientist for OpenAI who until November 2024 led safety-related research and programs for first-time product launches and more-speculative long-term AI systems about both—and what he thinks might have gone wrong. The interview has been edited for length and clarity. What do you make of these two incidents in recent weeks—ChatGPT’s sudden sycophancy and Grok’s South Africa obsession—of AI models going haywire? The high-level thing I make of it …

There we were: two experienced professionals, each standing on the iconic red dot of our own TEDx stages, ready to deliver what we hoped would be the most impactful talks of our careers. For Jamie, her meticulously rehearsed opening line—the one she practiced 327 times in the shower, in the mirror, and in front of a very patient partner—evaporated the moment the spotlight hit. Hundreds of expectant eyes waited as the silence stretched . . . and stretched. “Oh @*#%,” she whispered—into the mic. What was meant to be a private moment of panic turned into a public announcement. But instead of recoiling, the audience leaned in. Scott was one minute and fifty secon…

When Greg Giczi retired in February, his company threw him a party. Giczi had spent 12 years as president and general manager of WNIT-TV, a public television station based in South Bend, Indiana. Public broadcasting isn’t known for lavish budgets, so the party took place at the studio—a “big, open space with dramatic lighting,” Giczi describes. There were appetizers, wine, and beer, as well as heartfelt speeches. A huge snowstorm hit that night. But that didn’t stop a roomful family, coworkers, and others from coming out to celebrate Giczi; one person traveled over two-and-a-half hours. The board knew Giczi had been eyeing some electronics, so they gave him a “ni…

Hello and welcome to Modern CEO! I’m Stephanie Mehta, CEO and chief content officer of Mansueto Ventures. Each week this newsletter explores inclusive approaches to leadership drawn from conversations with executives and entrepreneurs, and from the pages of Inc. and Fast Company. If you received this newsletter from a friend, you can sign up to get it yourself every Monday morning. Long before the The President administration tapped Elon Musk to cut federal costs and headcount via the Department of Government Efficiency (DOGE), business leaders and politicians have been trying to find ways to make government leaner, less bureaucratic, and more like a well-run corporat…

In recent years, the FDA has approved dozens of gene and cell therapies that can potentially cure rare diseases like sickle cell disease and spinal muscular atrophy. But many patients still can’t access these treatments because insurers have refused to cover them. That reluctance is understandable, unfortunately. Widespread use of these multimillion-dollar therapies would bankrupt many health insurers. But the solution isn’t to deny lifesaving drugs to patients. Rather, it is to deploy creative financing solutions that deliver these therapies to sick Americans without collapsing the insurance system. The sickle cell dilemma Consider, for instance, the dil…

The Soviet Union launched over a dozen probes to Venus—most successfully. But one never made it past Earth’s orbit and has, in fact, stayed there since 1972. Now, over 50 years later, the one-meter-large Kosmos 482 is coming home, albeit a bit haphazardly. The 1,091-pound craft, also known as Kosmos 482 and Venera 8, is predicted to reach reentry within nine hours of 1:54 a.m. ET on May 10, according to the Center for Orbital and Reentry Debris Studies (CORDS). In other words, this could be late afternoon today or sometime tomorrow morning. If you think the when is varied, wait until you hear about the where. Aerospace, the American nonprofit resea…

Want more housing market stories from Lance Lambert’s ResiClub in your inbox? Subscribe to the ResiClub newsletter. When assessing home price momentum, ResiClub believes it’s important to monitor active listings and months of supply. If active listings start to rapidly increase as homes remain on the market for longer periods, it may indicate pricing softness or weakness. Conversely, a rapid decline in active listings could suggest a market that is tightening or heating up. Since the national Pandemic Housing Boom fizzled out in 2022, the national power dynamic has slowly been shifting directionally from sellers to buyers. Of course, across the country that shift …